TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
+35.4%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$83M
AUM Growth
+$83M
(-35%)
Cap. Flow
-$69.8M
Cap. Flow
% of AUM
-84.13%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Revolution Medicines
RVMD
|
$38.2M |
| 2 |
Voyager Therapeutics
VYGR
|
$17.3M |
| 3 |
Fulcrum Therapeutics
FULC
|
$14.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pliant Therapeutics
PLRX
$101M
| $48.9M | 58.97% |
1,839,160
| – | – |
|
|
2
Voyager Therapeutics
VYGR
$186M
| $24.6M | 29.6% |
3,185,291
-2,243,642
| -41% | -$17.3M |
|
|
DBTX
3
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $9.48M | 11.43% |
3,139,685
| – | – |
|
|
4
Fulcrum Therapeutics
FULC
$351M
| – | – |
-1,962,202
| Closed | -$14.3M |
|
|
5
Revolution Medicines
RVMD
$7.1B
| – | – |
-1,604,130
| Closed | -$38.2M |
|